Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Posterior fossa hemangioblastomas].

M Gelabert González1

  • 1Instituto Universitario de Ciencias Neurologicas, Facultad de Medicina, Universidad de Santiago de Compostela, Spain. cimigego@usc.es

Neurologia (Barcelona, Spain)
|August 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Minimally invasive treatment of chronic subdural haematoma in adults: results in 116 patients].

Neurologia (Barcelona, Spain)·2012
Same author

[Intracranial ependymomas].

Revista de neurologia·2002
Same author

[Acute inter-hemispheric subdural hematoma].

Neurocirugia (Asturias, Spain)·2001
Same author

[Trigeminal neuralgia as the first symptom of Chiari malformation].

Neurologia (Barcelona, Spain)·2001
Same author

[Spinal meningiomas].

Neurologia (Barcelona, Spain)·2000
Same author

[Malignant lumbago-sciatica].

Revista clinica espanola·1994
Same journal

[Amyotrophic neuralgia secondary to Vaxzevria (AstraZeneca) COVID-19 vaccine].

Neurologia (Barcelona, Spain)·2024
Same journal

[SARS-CoV-2 infection: Possible underdiagnosis of cerebral venous sinus thrombosis].

Neurologia (Barcelona, Spain)·2024
Same journal

[Bell's palsy following COVID-19 vaccination: A case report].

Neurologia (Barcelona, Spain)·2024
Same journal

[Parsonage-Turner syndrome post-infection by SARS-CoV-2: A case report].

Neurologia (Barcelona, Spain)·2024
Same journal

[Acute transverse myelitis following SARS-CoV-2 infection].

Neurologia (Barcelona, Spain)·2024
Same journal

[Neurological complications in critical patients with COVID-19].

Neurologia (Barcelona, Spain)·2024
See all related articles

Posterior fossa hemangioblastomas are benign tumors primarily affecting young adults. Surgical resection offers a cure, but recurrence depends on von Hippel-Lindau disease and lesion number.

Area of Science:

  • Neurosurgery
  • Oncology
  • Neuropathology

Background:

  • Hemangioblastomas are rare, benign tumors constituting 1-2% of primary nervous system tumors.
  • These lesions predominantly affect young adults, with a peak incidence in the fourth decade of life.
  • They are frequently found in the posterior fossa, accounting for 8-12% of lesions in this region.

Discussion:

  • This study analyzed 24 posterior fossa hemangioblastomas in 22 patients treated surgically between 1980 and 2006.
  • The average patient age was 39.1 years, with tumors located in the cerebellum and brainstem.
  • Complete tumor removal was achieved in 95% of cases, with 16 cystic and 8 solid lesions identified.

Key Insights:

  • Hemangioblastomas, while benign, can be associated with von Hippel-Lindau (VHL) disease in about 25% of cases.

Related Experiment Videos

  • Surgical resection is the primary curative treatment for most hemangioblastomas.
  • Long-term recurrence is influenced by the presence of VHL disease and multiple lesions.

    • Outlook:

    • Further research into the genetic underpinnings of sporadic hemangioblastomas may reveal novel therapeutic targets.
    • Long-term surveillance is crucial for patients with VHL disease or multiple tumors to monitor for recurrence.
    • Understanding the factors influencing recurrence can optimize post-operative management and patient outcomes.